The gene synthesis market would grow at a CAGR of 19.45% over the predicted time frame. The market is expected to increase in value from US$ 2.51 Bn in 2022 to US$ 10.4 Bn in 2030.
Key Takeaways:
- North America accounted highest revenue share of 39% in 2021.
- By method, the solid-phase synthesis segment has accounted revenue share of 37% in 2021.
- By service, the antibody DNA synthesis segment has captured 61% revenue share in 2021.
- By application, the gene & cell therapy development segment has generated 36% revenue share in 2021.
- By end use, the academic and government research institutes segment accounting revenue share of 56% in 2021.
The on gene synthesis Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2278
A recent report provides crucial insights along with application based and forecast information in the Global Gene synthesis Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Gene synthesis market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Gene synthesis market are included as given below:
Gene synthesis Market Key Players are: OriGene Technologies,Inc, Integrated DNA Technologies, Inc, Thermo Fisher Scientific, Inc, ProMab Biotechnologies, Inc, Eurofins Scientific, Biomatik, ProteoGenix, Bosyer Biological Technology, GenScript, Brooks Automation, Inc (GENEWIZ), Twist Bioscience, Codex DNA
Market Segments
By Method
- Solid-phase synthesis
- Chip-based synthesis
- PCR- based Enzyme synthesis
By Service
- Antibody DNA synthesis
- Viral DNA synthesis
- Others
By Application
- Gene & cell therapy development
- Vaccine development
- Diseases diagnosis
- Others
By End Users
- Biotechnology & pharmaceutical companies
- Academic & government research institutes
- Contract research organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global gene synthesis market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the gene synthesis market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Gene Synthesis Market
5.1. COVID-19 Landscape: Gene Synthesis Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Gene Synthesis Market, By Method
8.1. Gene Synthesis Market, by Method, 2022-2030
8.1.1. Solid-phase synthesis
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Chip- based synthesis
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. PCR- based Enzyme synthesis
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Gene Synthesis Market, By Service
9.1. Gene Synthesis Market, by Service, 2022-2030
9.1.1. Antibody DNA synthesis
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Viral DNA synthesis
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Gene Synthesis Market, By Application
10.1. Gene Synthesis Market, by Application, 2022-2030
10.1.1. Gene & cell therapy development
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Vaccine development
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Diseases diagnosis
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Gene Synthesis Market, By End Users
11.1. Gene Synthesis Market, by End Users, 2022-2030
11.1.1. Biotechnology & pharmaceutical companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Academic & government research institutes
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Contract research organizations
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Gene Synthesis Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Method (2017-2030)
12.1.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End Users (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End Users (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Method (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End Users (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Method (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End Users (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Method (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End Users (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Method (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End Users (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Method (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End Users (2017-2030)
Chapter 13. Company Profiles
13.1. OriGene Technologies,Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Integrated DNA Technologies, Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific, Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ProMab Biotechnologies, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Eurofins Scientific
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Biomatik
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. ProteoGenix
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Bosyer Biological Technology
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GenScript
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Brooks Automation, Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments